Scientists have reached a critical point in the development of new therapies for prostate cancer.

The information gleaned from the Human Genome Project, alongside the emergence of new technologies for the use of genetic data, has expanded the physician's understanding of disease progression and widened his armamentarium for prostate cancer prevention.